Morten Hedetoft

636 total citations
23 papers, 275 citations indexed

About

Morten Hedetoft is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Morten Hedetoft has authored 23 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 11 papers in Infectious Diseases and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Morten Hedetoft's work include Streptococcal Infections and Treatments (15 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Diabetic Foot Ulcer Assessment and Management (6 papers). Morten Hedetoft is often cited by papers focused on Streptococcal Infections and Treatments (15 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Diabetic Foot Ulcer Assessment and Management (6 papers). Morten Hedetoft collaborates with scholars based in Denmark, Sweden and Norway. Morten Hedetoft's co-authors include Ole Hyldegaard, Martin Bruun Madsen, Niels Vidiendal Olsen, Michael H Bennett, Marco Bo Hansen, Anders Perner, Per Arnell, Steinar Skrede, Anna Norrby‐Teglund and Michael Nekludov and has published in prestigious journals such as Scientific Reports, Journal of Applied Physiology and Intensive Care Medicine.

In The Last Decade

Morten Hedetoft

18 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morten Hedetoft Denmark 8 174 133 64 38 33 23 275
Linda Corcoran United States 6 89 0.5× 44 0.3× 16 0.3× 19 0.5× 48 1.5× 8 441
Kazumi Ikeda Japan 11 79 0.5× 23 0.2× 15 0.2× 31 0.8× 95 2.9× 16 356
Ilaria Corsini Italy 12 48 0.3× 126 0.9× 12 0.2× 6 0.2× 17 0.5× 29 355
Alexandra Fleva Greece 7 31 0.2× 76 0.6× 43 0.7× 4 0.1× 28 0.8× 14 301
Wouter de Waal Netherlands 4 41 0.2× 25 0.2× 22 0.3× 23 0.6× 8 0.2× 5 188
Nguyen TH United Kingdom 5 39 0.2× 122 0.9× 18 0.3× 4 0.1× 7 0.2× 10 365
Dan Reich Israel 10 31 0.2× 61 0.5× 6 0.1× 22 0.6× 17 0.5× 15 316
M.J. Ricart Spain 10 51 0.3× 24 0.2× 14 0.2× 14 0.4× 11 0.3× 21 327
Claude Scheidegger Switzerland 7 39 0.2× 47 0.4× 12 0.2× 6 0.2× 15 0.5× 13 192
Josef Widerhorn United States 8 58 0.3× 22 0.2× 48 0.8× 5 0.1× 19 0.6× 9 480

Countries citing papers authored by Morten Hedetoft

Since Specialization
Citations

This map shows the geographic impact of Morten Hedetoft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morten Hedetoft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morten Hedetoft more than expected).

Fields of papers citing papers by Morten Hedetoft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morten Hedetoft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morten Hedetoft. The network helps show where Morten Hedetoft may publish in the future.

Co-authorship network of co-authors of Morten Hedetoft

This figure shows the co-authorship network connecting the top 25 collaborators of Morten Hedetoft. A scholar is included among the top collaborators of Morten Hedetoft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morten Hedetoft. Morten Hedetoft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hyldegaard, Ole, Michael Nekludov, Per Arnell, et al.. (2025). Use of Hyperbaric Oxygen in Patients with Necrotizing Soft Tissue Infections: A Scandinavian Multicenter, Prospective, Observational Cohort. Infectious Diseases and Therapy. 14(8). 1715–1738.
2.
Saccenti, Edoardo, et al.. (2025). Effects of disease severity on RNA integrity measures in necrotising soft tissue infection as a possible source of research bias: An observational cohort study. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1868(4). 195121–195121.
3.
4.
Hedetoft, Morten, Martin Bruun Madsen, & Ole Hyldegaard. (2023). Hyperbaric oxygen treatment in the management of necrotising soft-tissue infections: results from a Danish nationwide registry study. BMJ Open. 13(2). e066117–e066117. 2 indexed citations
5.
Sura, Thomas, Kirsten Moll, Bhavya Chakrakodi, et al.. (2023). Neutrophil-derived reactive agents induce a transient SpeB negative phenotype in Streptococcus pyogenes. Journal of Biomedical Science. 30(1). 52–52. 5 indexed citations
6.
Rib, Leonor, et al.. (2023). Key pathways and genes that are altered during treatment with hyperbaric oxygen in patients with sepsis due to necrotizing soft tissue infection (HBOmic study). European journal of medical research. 28(1). 507–507. 4 indexed citations
7.
8.
Hedetoft, Morten, Martin Bruun Madsen, Cecilie Bo Hansen, Ole Hyldegaard, & Peter Garred. (2021). Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue Infection. Journal of Innate Immunity. 14(4). 355–365.
9.
Hedetoft, Morten, Marco Bo Hansen, Martin Bruun Madsen, Julia S. Johansen, & Ole Hyldegaard. (2021). Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection. BMC Infectious Diseases. 21(1). 1046–1046. 4 indexed citations
10.
Hedetoft, Morten, Michael H Bennett, & Ole Hyldegaard. (2021). Adjunctive hyperbaric oxygen treatment for necrotising soft-tissue infections: A systematic review and meta-analysis. Diving and Hyperbaric Medicine Journal. 51(1). 34–43. 26 indexed citations
11.
Hedetoft, Morten, Peter Garred, Martin Bruun Madsen, & Ole Hyldegaard. (2021). Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft‐tissue infection. Physiological Reports. 9(6). e14757–e14757. 20 indexed citations
12.
Hedetoft, Morten, et al.. (2021). Soluble ICAM-1 is modulated by hyperbaric oxygen treatment and correlates with disease severity and mortality in patients with necrotizing soft-tissue infection. Journal of Applied Physiology. 130(3). 729–736. 10 indexed citations
13.
14.
Hedetoft, Morten, et al.. (2020). Measurement of peripheral arterial tonometry in patients with diabetic foot ulcers during courses of hyperbaric oxygen treatment. Diving and Hyperbaric Medicine Journal. 50(1). 17–23. 2 indexed citations
15.
Hyldegaard, Ole & Morten Hedetoft. (2020). [Hyperbaric oxygen therapy].. PubMed. 182(44). 7 indexed citations
16.
Madsen, Martin Bruun, Steinar Skrede, Anders Perner, et al.. (2019). Patient’s characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study. Intensive Care Medicine. 45(9). 1241–1251. 90 indexed citations
17.
18.
Hedetoft, Morten, et al.. (2018). Neuronal nitric oxide inhibition attenuates the protective effect of HBO2 during cyanide poisoning. Undersea and Hyperbaric Medicine. 45(3). 335–350. 1 indexed citations
19.
Hedetoft, Morten & Ole Hyldegaard. (2016). Postural stability in patients with decompression sickness evaluated by means of Quantitative Romberg testing.. PubMed. 42(5). 389–98.
20.
Hedetoft, Morten & Niels Vidiendal Olsen. (2014). Evaluation of endothelial function by peripheral arterial tonometry and relation with the nitric oxide pathway. Nitric Oxide. 42. 1–8. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Corcoran Breakdown of academic impact, for papers by Kazumi Ikeda Breakdown of academic impact, for papers by Ilaria Corsini Breakdown of academic impact, for papers by Alexandra Fleva Breakdown of academic impact, for papers by Wouter de Waal Breakdown of academic impact, for papers by Nguyen TH Breakdown of academic impact, for papers by Dan Reich Breakdown of academic impact, for papers by M.J. Ricart Breakdown of academic impact, for papers by Claude Scheidegger Breakdown of academic impact, for papers by Josef Widerhorn
Rankless by CCL
2026